Features
Flipbooks
Transform any piece of content into a page-turning experience.
Fullscreen Sharing
Deliver a distraction-free reading experience with a simple link.
Embed
Host your publication on your website or blog with just a few clicks.
Statistics
Make data-driven decisions to drive reader engagement, subscriptions, and campaigns.
Teams
Enable groups of users to work together to streamline your digital publishing.
Social Posts
Create on-brand social posts and Articles in minutes.
GIFs
Highlight your latest work via email or social media with custom GIFs.
Add Links
Send readers directly to specific items or pages with shopping and web links.
Video
Say more by seamlessly including video within your publication.
Digital Sales
Sell your publications.
QR Codes
Generate QR Codes for your digital content.
More Features
Integrations
Canva
Create professional content with Canva, including presentations, catalogs, and more.
Adobe Express
Go from Adobe Express creation to Issuu publication.
Adobe InDesign
Design pixel-perfect content like flyers, magazines and more with Adobe InDesign.
Use Cases
Industry
Art, Architecture, and Design
Education
Internal Communications
Marketing and PR
Nonprofits
Publishing
Real Estate
Retail and Wholesale
Travel and Tourism
More Industries
Role
Content Marketers
Designers
Publishers
Salespeople
Social Media Managers
Content Type
Flipbook
Portfolio
Digital Magazine
Digital Flipbook
PDF to Flipbook
Newspaper
Digital Book
Digital Lookbook
More Content Types
More
Issuu Store
Purchase your next favourite publication
Help Center
Here you'll find an answer to your question.
Resources
Dive into our extensive resources on the topic that interests you. It's like a masterclass to be explored at your own pace.
Air Quality: Why Are European Policies for Climate and Health in a Turning Point? (40)
COVID-19 Vaccines: What Are the Global Health Consequences of a Third Dose? (39)
Vacuna COVID: ¿Qué consecuencias tiene una tercera dosis en la salud global? (39)
COVID Vaccines: Do We Need a Booster Dose Now?
Vacunes COVID-19: Ens cal una dosi de reforç en aquest moment?
How to Respond to COVID-19 in a Small Island State? (38)
¿Cómo responder a la COVID-19 desde un Estado insular pequeño? (38)
The Chilean Paradox: Why Are Cases Rising Despite High Levels of Vaccination? (37)
What Is Long COVID and What Can We Do to Address the Problem? (36)
La paradoja chilena: ¿por qué aumentan los casos a pesar de las altas tasas de vacunación? (37)
¿Qué es la COVID prolongada y qué podemos hacer frente a ella? (36)
Will We Be Able to Achieve Herd Immunity Against COVID-19? (35)
¿Seremos capaces de alcanzar la inmunidad de grupo para la COVID-19? (35)
What Can We Expect From the G20 and EU Global Health Summit? (34)
¿Qué podemos esperar de la Cumbre del G20 y la UE sobre Salud Global? (34)
COVID-19, Global Cooperation and Reigniting the Economy: Do we Need Vaccine Certificates? (33)
COVID-19, cooperación global y reactivación económica: ¿pasaportes de vacunación? (33)
Ivermectin and COVID-19: What’s Going On? (31)
Will We See a Wave of Mental Health Problems After the COVID-19 Pandemic? (32)
¿Es la salud mental la pandemia después de la COVID-19? (32)
Biomedical R&D and Innovation: How Can We Protect the Public Interest After COVID-19? (30)
Ivermectina y COVID-19: ¿qué está pasando? (31)
R+D+I biomèdica: com s’ha de protegir l’interès públic després de la COVID-19? (30)
I+D+i biomédico: ¿cómo proteger el interés público tras la COVID-19? (30)
How Is COVID-19 Affecting Pregnant Women? (29)
ISGlobal
